Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (81-90 of 329) with videos related to

Pageof 33
Sort By:
ERJ Open Research|August 29, 2017
Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinomaMichaël Duruisseaux, Nathalie Rabbe, Martine Antoine, et al.
ERJ Open Research|June 24, 2022
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challengesNamrata Kewalramani, Carlos Machahua, Venerino Poletti, et al.
Presse Medicale (Paris, France : 1983)|November 25, 2025
Pulmonary toxicity of immune-checkpoint inhibitorsCédric Mahiat, Jacques Cadranel, Vincent Fallet, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2021
A Severe COVID-19 Pneumonia Revealing a Lepidic Adenocarcinoma: A Diagnostic Challenge during the Pandemic PeriodAlexandre Elabbadi, Anne Fajac, Martine Antoine, et al.
Lung Cancer (Amsterdam, Netherlands)|October 20, 2007
Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancerValérie Gounant, Marie Wislez, Virginie Poulot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinomaMarie Wislez, David G Beer, Ignacio Wistuba, et al.
Annales De Pathologie|January 19, 2016
[News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)]Cécile Hamard, Anne-Marie Ruppert, Armelle Lavole, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to BrigatinibCamille Mehlman, Nouha Chaabane, Roger Lacave, et al.
Journal of Thoracic Disease|August 3, 2018
Lung cancer and interstitial lung disease: a literature reviewJean-Marc Naccache, Quentin Gibiot, Isabelle Monnet, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Pageof 33

Showing results (81-90 of 329) with videos related to

Sort By:
Pageof 33
ERJ Open Research|August 29, 2017
Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinomaMichaël Duruisseaux, Nathalie Rabbe, Martine Antoine, et al.
ERJ Open Research|June 24, 2022
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challengesNamrata Kewalramani, Carlos Machahua, Venerino Poletti, et al.
Presse Medicale (Paris, France : 1983)|November 25, 2025
Pulmonary toxicity of immune-checkpoint inhibitorsCédric Mahiat, Jacques Cadranel, Vincent Fallet, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2021
A Severe COVID-19 Pneumonia Revealing a Lepidic Adenocarcinoma: A Diagnostic Challenge during the Pandemic PeriodAlexandre Elabbadi, Anne Fajac, Martine Antoine, et al.
Lung Cancer (Amsterdam, Netherlands)|October 20, 2007
Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancerValérie Gounant, Marie Wislez, Virginie Poulot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinomaMarie Wislez, David G Beer, Ignacio Wistuba, et al.
Annales De Pathologie|January 19, 2016
[News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)]Cécile Hamard, Anne-Marie Ruppert, Armelle Lavole, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to BrigatinibCamille Mehlman, Nouha Chaabane, Roger Lacave, et al.
Journal of Thoracic Disease|August 3, 2018
Lung cancer and interstitial lung disease: a literature reviewJean-Marc Naccache, Quentin Gibiot, Isabelle Monnet, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Pageof 33